Skip to main content

Remote Job Finders (RJF)

Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact

Vertex Pharmaceuticals commits $45 million upfront to leverage Enlaza Therapeutics’ War-Lock platform to create drug conjugates and T cell engagers for autoimmune diseases and gentler conditioning for sickle cell/beta thalassemia gene-editing therapy Casgevy.

Massachusetts R&D, Biomanufacturing Jobs Fell in ’24: Report

Massachusetts biopharma workforce growth was fairly flat last year, and R&D and manufacturing employment declined, according to a new MassBio report. BioSpace data further highlight challenges facing the state, showing roughly 2,300 people out of work in 2025 and jobs live on the website falling.
Scroll to top